Calcium-selective transient receptor potential vanilloid subfamily member 6 (TRPV6) channels play a critical role in calcium uptake in epithelial tissues 1-4 . Altered TRPV6 expression is associated with a variety of human diseases 5 , including cancers 6 . TRPV6 channels are constitutively active 1,7,8 and their open probability depends on the lipidic composition of the membrane in which they reside; it increases substantially in the presence of phosphatidylinositol 4,5-bisphosphate 7,9 . Crystal structures of detergent-solubilized rat TRPV6 in the closed state have previously been solved 10,11 . Corroborating electrophysiological results 3 , these structures demonstrated that the Ca 2+ selectivity of TRPV6 arises from a ring of aspartate side chains in the selectivity filter that binds Ca 2+ tightly. However, how TRPV6 channels open and close their pores for ion permeation has remained unclear. Here we present cryo-electron microscopy structures of human TRPV6 in the open and closed states. The channel selectivity filter adopts similar conformations in both states, consistent with its explicit role in ion permeation. The iris-like channel opening is accompanied by an α-to-π-helical transition in the pore-lining transmembrane helix S6 at an alanine hinge just below the selectivity filter. As a result of this transition, the S6 helices bend and rotate, exposing different residues to the ion channel pore in the open and closed states. This gating mechanism, which defines the constitutive activity of TRPV6, is, to our knowledge, unique among tetrameric ion channels and provides structural insights for understanding their diverse roles in physiology and disease.
Letter reSeArCH 2 3 4 | n a T u r E | V O L 5 5 3 | 1 1 j a n u a r y 2 0 1 8 head-and-two-tails appearance. Fitting different lipid molecules into density 4 (Extended Data Fig. 5a -c) suggests that the chemical environment around the lipid head group, including the negatively charged aspartate D525 and polar Y349, Y509, Q513 and Y524 residues, supports binding of phosphatidylethanolamine or phosphatidylcholine rather than phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ). Densities 1-3 have sausage-like appearances and might represent a wider variety of lipid-like molecules, including cholesterol or cholesterol hemisuccinate (CHS) (Extended Data Fig. 5d, e ). In physiological conditions, some of these sites can bind PtdIns(4,5)P 2 7,9 . For example, the positively charged R470 and K484 and polar T479, Q483 and Q596 residues around density 2 create a permissive chemical environment for the negatively charged head group of PtdIns(4,5)P 2 . However, the poor fit of PtdIns(4,5)P 2 into density 2 (Extended Data Fig. 5f ) suggests that in our cryo-EM structure, density 2 represents a different molecule.
In the crystal structure of rTRPV6 in the closed state, the M577 side chains form a hydrophobic 'seal' on the cytoplasmic side of the S6 helices 10,11 . By contrast, interatomic distances within the pore of the new structure confirmed that the hTRPV6 channel pore is open (Fig. 3) . The pore surface is lined by the side chains of D542, T539, N572, I575, D580 and W583, as well as the backbone-carbonyl oxygens of I540, I541 and G579. The narrowest part of the upper pore, the selectivity filter, is formed by the D542 side chains, one from each subunit, which project towards the centre of the pore (Fig. 3a , c, f). We propose that D542 in hTRPV6, similar to D541 in rTRPV6, plays an important role in Ca 2+ permeation by directly coordinating dehydrated Ca 2+ ions 11 . The narrowest part of the hTRPV6 lower pore (9.6 Å interatomic distance) is defined by the side chains of I575 at the S6 bundle crossing (Fig. 3a, c, d ). This part of the pore is comparable in size to the pore of open TRPV1 (9.3 Å interatomic distance, measured between side chains of I679) 18 and is wide open for conductance of hydrated Na + or Ca 2+ ions.
Along the axis of the hTRPV6 pore, there is a strong density about 3.9 Å away from the side chains of D542 ( Fig. 2d ) that is likely to represent a Ca 2+ ion bound to a site homologous to the main Ca 2+ -binding site (site 1) at D541 in the pore of rTRPV6 10, 11 . An additional strong density along the hTRPV6 pore is observed at the bundle crossing of the S6 helices, about 8.0 Å away from D580 and about 6.6 Å away from W583, suggesting that these residues may play an important role in ion permeation ( Fig. 2e ). Indeed, W583 is conserved in TRPV6 and TRPV5 channels and is involved in the regulation of calcium uptake, as shown by mutation W583A in TRPV5, which induces cell death due to increased calcium influx 19 . The density at the S6 helices bundle crossing, which was not observed in the pore of the closed-state rTRPV6 10,11 , is likely to represent another permeant ion bound in the open pore of hTRPV6.
To determine the structure of hTRPV6 in the closed state, we decided to shift the open-closed state gating equilibrium towards the closed state by interfering with channel activation. Because the open probability of TRPV6 is strongly dependent on membrane lipids 7,9 , altering lipid binding by mutagenesis might result in channel closure. TRPV1, for example, is activated through an intramembrane vanilloid-binding site ( Fig. 4a ), which accommodates agonists, such as resiniferatoxin (RTX) and capsaicin, and antagonists, such as capsazepine (CPZ) 18 . In the absence of ligands, this site is occupied by the lipid phosphatidylinositol, which favours the closed pore conformation 18 . The TRPV1 vanilloid-binding site coincides with hTRPV6 lipid density 2, which may represent the binding site for natural lipid agonists ( Fig. 4b ).
To test whether this site is critical for channel activation, we mutated R470 to glutamate (R470E). An analogous mutation has previously been shown to eliminate capsaicin-evoked currents in TRPV1 20 . The mutant hTRPV6(R470E) channels were functional (Extended Data Fig. 1b ) but their calcium uptake was about ten times slower than that of wild-type channels (Extended Data Fig. 1e , f), consistent with their less frequent openings. In addition, 2-APB, a TRPV6 inhibitor that acts through the membrane, showed increased affinity to and decreased maximum inhibition of hTRPV6(R470E) compared to wild-type channels (Extended Data Fig. 1i -k), consistent with the R470E mutation altering regulation of TRPV6 by lipids.
We solved the hTRPV6(R470E) structure in amphipols by cryo-EM to 4.2 Å resolution (Extended Data Fig. 6 ). Consistent with the idea that the site 2 density represents an activating lipid, this density was smaller in hTRPV6(R470E) ( Fig. 4c ) than in hTRPV6 ( Fig. 4b ). Confirming that the physical occupancy of site 2 differed, the side chain of Q483 in hTRPV6(R470E) has an altered conformation that would cause clashing with the lipid density in wild-type hTRPV6 (Fig. 4b, c ). Supporting the role of Q483 in lipid recognition, an hTRPV6(Q483A) mutant, while being functional (Extended Data Fig. 1c ), showed an approximately five times slower calcium uptake than wild-type channels (Extended Data Fig. 1e, g) . Notably, the ion channel in hTRPV6(R470E) appears to be closed (Fig. 3b , c, e). Indeed, the size of the pore at the S6 bundle crossing becomes comparable to the narrowest point of the selectivity filter. While the latter is formed by the side chains of D542, which directly coordinate calcium ions for selective permeation, the S6 bundle crossing is formed by the side chains of L574 and M578, which create a hydrophobic seal impermeable to ions and water, and therefore represent the channel gate.
The closed-state structure of hTRPV6(R470E) is nearly identical to the closed-state crystal structure of rat TRPV6 (rTRPV6) 10 and their superposition yields a root mean square deviation (r.m.s.d.) of 0.917 Å. To verify that the rTRPV6 crystal structure represents the physiologically relevant conformation, we solved the structure of rTRPV6 by cryo-EM to 3.9 Å using a lipid nanodisc preparation similar to that used for hTRPV6 (Extended Data Fig. 7) . Strikingly, the cryo-EM structure of rTRPV6 is nearly identical (r.m.s.d. = 0.781 Å) to the crystal structure of rTRPV6 (Extended Data Fig. 8a-c ). As the hTRPV6(R470E) structure is nearly identical to both the rTRPV6 cryo-EM structure (Extended Data Fig. 8d , e, r.m.s.d. = 0.932 Å) and the rTRPV6 crystal structure, we contend that it represents the true closed state of hTRPV6. Consistently, a much weaker density at site 2 in the cryo-EM structure of rTRPV6 ( Fig. 4d ) suggests either lower occupancy or greater mobility of the putative bound lipid. Because rTRPV6 and hTRPV6 were purified in similar conditions, have 89% overall sequence identity, and have identical amino acid compositions of their site 2 lipid-binding pockets, it remains unclear why one channel was closed and the other open. For example, some lipids within the membranes of the protein-expressing HEK 293 cells may be important for opening of hTRPV6 but not rTRPV6. Different conformations of rTRPV6 and hTRPV6 might also reflect the ease with which these constitutively active channels rapidly transition between gating states, and that very subtle changes can push this equilibrium towards one state or the other. alanine hinge in TRPV6, allows gating of K + channels to occur at the inner helices bundle crossing without changing the selectivity filter. However, unlike TRPV6, the glycine gating hinge in K + channels does not introduce a 100° rotation of the lower parts of the pore-forming helices and correspondingly does not change the residues that line the pore gate region. An alanine gating hinge is present in the poreforming helices of ionotropic glutamate receptor (iGluR) family tetrameric ion channels 28 . However, this alanine gating hinge is located at the ion channel gate region. Correspondingly, bending the pore-forming helices at the iGluR alanine gating hinge directly alters the diameter of the pore in close proximity to the gate without an α-to-π transition. The alanine gating hinge in TRPV5 and TRPV6 channels is therefore a unique structural element that is likely to be associated with their exclusive physiological role as constitutively active calcium uptake channels.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Such subtle changes, for instance, can originate from different interactions of the membrane-mimicking environment (amphipols or nanodiscs) with helices S1-S3. These helices contain the largest number of membrane lipid-facing residues (69%), of which only 80% are identical between rTRPV6 and hTRPV6.
To understand the structural changes that occur during TRPV6 opening, we compared our hTRPV6(R470E) and hTRPV6 structures. The principal changes occur in the pore-lining helix S6 and originate at A566, which is highly conserved in TRPV5 and TRPV6 (Extended Data Fig. 9k ) and located right below the selectivity filter ( Fig. 3g ). Confirming its important role in gating, substitution of A566 with threonine, the homologous residue conserved in TRPV1-4, greatly reduced the TRPV6 current amplitude (Extended Data Fig. 1d ) and slowed calcium uptake by approximately 30 times (Extended Data Fig. 1e , h). Upon opening, S6, which has an α-helical conformation in the closed state, undergoes a local transition to a π-helix. Notably, such a transition has been hypothesized previously, based on a comparison between the TRPV1 and TRPV2 structures 21 . Concurrently, the lower part of S6, which forms the gate in the closed state, rotates by about 100° and bends away from the pore axis by about 11° (Fig. 3g ). These rearrangements not only widen the pore for permeant ions but also change the set of residues that face the pore axis (for example, N572 and I575 in the open state compared to L574 and M578 in the closed state). Alanine A566, therefore, acts as a hinge to allow TRPV6 gating at the S6 bundle crossing without changing the conformation of the selectivity filter ( Fig. 3f ). Correspondingly, the selectivity filter appears to play a crucial role in TRPV6 channel ion permeation rather than gating. Gating-related conformational changes induced by the α-to-π-helical transition in S6 seem to involve only the intracellular portions of S5 and S6, the S4-S5 linker and the TRP helix. Indeed, superposition of the corresponding regions (residues 469-500 plus 566-608) in hTRPV6 and hTRPV6(R470E) gives an r.m.s.d. of 1.74 Å, while the rest of the molecules superpose with a much lower r.m.s.d. of 0.218 Å.
Within the regions involved in gating, pore opening in hTRPV6 is accompanied by the formation of two electrostatic bonds per subunit ( Fig. 4b) . A salt bridge forms between Q473 in the S4-S5 elbow and R589 in the TRP helix, and a hydrogen bond forms between D489 in the S5 helix and T581 in the S6 helix. Neither interaction is present in the closed-state structures of hTRPV6(R470E) or rTRPV6 and the formation of the hydrogen bond (D489-T581 in hTRPV6(R470E) or D488-T580 in rTRPV6) is prevented by the side chain of M577 or M576, respectively ( Fig. 4c, d , Extended Data Fig. 8f , g). The importance of the D489-T581 interaction for hTRPV6 opening is supported by the previous observation that a mutation equivalent to T581A reduces the excessive constitutive activity of an hTRPV6(G516S) mutant 22 . We speculate that formation of the electrostatic bonds compensates for the energetic cost of the unfavourable α-to-π-helical transition in S6 during channel opening. This structural solution therefore maintains the relative stabilities and similar energy levels of both gating states and supports the constitutive activity of TRPV6. Accordingly, the open and closed conformations of TRPV6 remain in a readily tunable equilibrium that can be shifted towards either state by different stimuli, including lipids 7,9 .
Our structures of hTRPV6 reveal a gating mechanism that is novel among tetrameric ion channels ( Fig. 5, Supplementary Video 1) . Although other representatives of the TRP channel family have a local α-to-π-helical transition in the middle of S6 18,23-25 , they lack the alanine gating hinge (Extended Data Fig. 9 ). As a result, S6 maintains its secondary structure throughout the entire TRPV1 gating cycle, the same residues face the pore in the closed and open states, and pore widening is observed at both the S6 bundle crossing and the selectivity filter 18 . On the other hand, K + channels do have a gating hinge in their pore-forming inner helices 26, 27 . However, this hinge is formed by a glycine located one residue C-terminally compared to the gating hinge alanine in TRPV6 and permits bending of the inner helices by about 30° without an α-to-π transition. The glycine hinge, like the 
Letter reSeArCH

MethODS
Construct. The full-length human TRPV6 (residues 1-725) and rat TRPV6 (rTRPV6, residues 1-727) were each introduced into a pEG BacMam vector 30 , with the C-terminal thrombin cleavage site (LVPRG) followed by the streptavidin affinity tag (WSHPQFEK). The R470E mutation in hTRPV6 was introduced by conventional mutagenesis. The rTRPV6 construct previously used for crystallographic studies, rTRPV6* (ref. 10), was also introduced into a pEG BacMam vector but with eGFP inserted between the thrombin site and the streptavidin tag. Compared to wild-type rTRPV6, the rTRPV6* construct is C-terminally truncated by 59 residues and contains three point mutations in the ankyrin repeat domain (I62Y, L92N and M96Q). Expression and purification. All constructs were expressed and purified similarly to TRPV6 cryst 11 . Bacmids and baculoviruses were made using a standard method 30 . The P2 baculovirus, produced in Sf9 cells (Thermo Fisher Scientific, mycoplasma negative, GIBCO #12659017), was added to HEK 293S cells lacking N-acetylglucosaminyltransferase I (GnTI − ) and grown in suspension (mycoplasma test negative, ATCC #CRL-3022) in Freestyle 293 medium (GIBCO-Life Technologies #12338-018) supplemented with 2% FBS at 37 °C and 5% CO 2 . Eight to twelve hours after transduction, 10 mM sodium butyrate was added to enhance protein expression and the temperature was reduced to 30 °C. At 48-72 h post-transduction, cells were harvested by low-speed centrifugation in a Sorvall Evolution RC Centrifuge (Thermo Scientific) at 5,471g for 15 min, washed in phosphate-buffered saline (PBS) pH 8.0, and pelleted in an Eppendorf Centrifuge 5810 at 3,202g for 10 min. The cell pellet was resuspended and subjected to sonication with a Misonix sonicator (12 × 15 s, power level 8) in a buffer containing 150 mM NaCl, 20 mM Tris-HCl (pH 8.0), 1 mM βME (β-mercaptoethanol) and protease inhibitors (0.8 μM aprotinin, 2 μg/ml leupeptin, 2 μM pepstatin A and 1 mM phenylmethysulfonyl fluoride); 50 ml was used per 800 ml of HEK 293 cell culture. Subsequently, the lysate was clarified after centrifugation using a Sorvall RC-5C Plus centrifuge at 9,900g for 15 min, and the membranes were collected by ultracentrifugation in a Beckman Coulter ultracentrifuge equipped with a Beckman Coulter Type 45 Ti Rotor at 186,000g for one hour. The membranes were then mechanically homogenized, and solubilized for 1-2 h in 150 mM NaCl, 20 mM Tris-HCl pH 8.0, 1% DDM (n-dodecyl-β-d-maltopyranoside), 0.1% CHS, and 1 mM βME. Insoluble material was removed by ultracentrifugation for 40 min in a Beckman Coulter Type 45 Ti Rotor at 186,000g and the supernatant was added to streptavidin-linked resin and rotated for 10-14 h at 4 °C. Next, the resin was washed with 10 column volumes of wash buffer containing 150 mM NaCl, 20 mM Tris-HCl pH 8.0, 1 mM βME, 0.1% DDM, and 0.01% CHS. The bound protein was eluted in wash buffer to which 2.5 mM d-desthiobiotin was added. All constructs were purified by size exclusion chromatography using a Superose 6 column equilibrated in 150 mM NaCl, 20 mM Tris-HCl pH 8.0, 1mM βME, 0.1% DDM, and 0.01% CHS. Tris(2-carboxyethyl)phosphine (TCEP; 10 mM) was added to the peak fractions, which were pooled and concentrated for channel reconstitution in nanodiscs or amphipols. The rTRPV6 and rTRPV6* constructs were expressed and purified similarly to the hTRPV6 constructs but without the addition of CHS to any buffer. Additionally, after elution from the streptavidinlinked resin, the rTRPV6* fusion protein was concentrated to ~1.0 mg/ml and subjected to thrombin digestion at a mass ratio of 1:100 (thrombin:protein) for one hour at 22 °C with rocking, before size exclusion chromatography. Prior to reconstitution in nanodiscs or amphipols, the concentration of each construct was adjusted to approximately 1.2 mg/ml. Reconstitution of TRPV6 protein into nanodiscs and amphipols. Both hTRPV6 and rTRPV6 were incorporated into conventional MSP2N2 lipid nanodiscs as described previously 18 . In brief, soybean polar lipid extract (Avanti #541602) was solubilized in buffer containing 20 mM Tris pH 8.0, 150 mM NaCl, 2 mM TCEP, and 15 mM DDM to create a 10-mM stock. Purified sample was mixed with the soybean polar lipid extract stock (~7.6 mg/ml) and MSP2N2 (~5.3 mg/ml) at a molar ratio of approximately 1:3:166 for both hTRPV6 (monomer: MSP2N2:lipid) and rTRPV6 (monomer:MSP2N2:lipid) and rocked at room temperature for one hour. Subsequently, 10 mg of Bio-beads SM2 (Bio-rad) pre-wet in buffer (20 mM Tris pH 8.0, 150 mM NaCl, 1mM βME) was added to 0.5 ml of mixture and the mixture was rotated at 4 °C. After one hour, an additional 10 mg of Bio-beads SM2 was added and the resulting mixture was rotated at 4 °C for ~20 h. The Bio-beads SM2 were removed by pipetting and TRPV6 reconstituted in nanodiscs was isolated from empty nanodiscs by size exclusion chromatography using a Superose 6 column equilibrated in 150 mM NaCl, 20 mM Tris-HCl pH 8.0, and 1 mM βME.
cNW11 circularized nanodiscs were prepared as described previously 31 . Purified rTRPV6* was incorporated into cNW11 (2.0 mg/ml) circularized nanodiscs using the procedure described above for the MSP2N2 nanodiscs but with a molar ratio of 1:10:267 (rTRPV6* monomer:cNW11:lipid).
For reconstitution in A8-35 amphipols (Anatrace #A835), we adapted the previously described procedure 32 . hTRPV6 or hTRPV6(R470E) was mixed with amphipols at a 1:3 mass ratio (protein:amphipols) and incubated for three hours with rotation at 4 °C. After three hours, 7-8 mg per 0.5 ml of mixture of Bio-beads SM2 pre-wet in buffer containing 20 mM Tris pH 8.0, 150 mM NaCl, 1mM βME was added to the protein-amphipols mixture to facilitate the reconstitution of TRPV6 into amphipols. The mixture was rotated for ~20 h at 4 °C and the amphipols-solubilized TRPV6 was purified as described above. Cryo-EM sample preparation and data collection. Au/Au grids were prepared as described 33 The hTRPV6 in nanodiscs data were collected on a Tecnai F30 Polara (C s 2.26 mm) at 300 kV equipped with a Gatan K2 Summit direct electron detection (DED) camera (Gatan) using Leginon 34 . We collected 1,733 micrographs in super-resolution mode with a pixel size of 0.98 Å across a defocus range of −1.5 μm to −3.5 μm. The total dose, ~67 e − Å −2 , was attained by using a dose rate of ~8.0 e − pixel −1 s −1 across 40 frames for 8 s total exposure time. We collected 1,538 hTRPV6 in amphipols micrographs and 1,301 rTRPV6* micrographs as described above. We collected 2,167 rTRPV6 micrographs as described above but in counting mode with a pixel size of 0.98 Å. The hTRPV6(R470E) data were collected on a C s -corrected Titan Krios (FEI) equipped with a post-column GIF Quantum energy filter at 300 kV. We collected 3,540 micrographs in counting mode with a pixel size of 1.10 Å across a defocus range of −1.5 μm to −3.5 μm. The total dose, ~67 e − Å −2 , was attained by using a dose rate of ~8.0 e − pixel −1 s −1 across 50 frames for 10 s total exposure time. Image processing. Data were collected using the Gatan K2 Summit DED camera (Gatan) in super-resolution mode and binned 2 × 2. Frame alignment was done using MotionCor2 35 . CTF correction, using CTFFIND4 36 for the hTRPV6 in nanodiscs dataset and gCTF 37 for all other datasets, was performed on non-doseweighted micrographs and subsequent data processing was done on dose-weighted micrographs. All other data processing, unless stated otherwise, was performed using Relion 2.0 38 . For each dataset, 1,000-2,000 particles were manually selected to generate 2D classes for use in auto-picking.
In processing the hTRPV6 in nanodiscs dataset, seven 2D classes were used for automatically picking 509,569 particles from the 1,733 collected micrographs. The particle images were binned to a pixel size of 1.96 Å per pixel and screened by 2D classification to remove aberrantly picked particles. The remaining 508,019 particles were subjected to 3D classification into 10 classes with no symmetry imposed. A density map was generated in Chimera from the crystal structure of rTRPV6 (PDB ID: 5IWK), low-pass filtered to 40 Å, and used as an initial reference. Five classes, comprising 313,369 particle images, exhibited structural features of a quality that warranted further processing. Of the five, one showed structural features of higher detail and comprised 71,582 particle images. The particle images composing this class were extracted without binning (0.98 Å per pixel), refined with C4 symmetry using the same reference (unbinned) as the prior round of classification, low-pass filtered to 40 Å, and post-processed. The resulting map was then used as a reference for the second round of 3D classification in which the particles composing the best five aforementioned classes were extracted with binning (1.98 Å per pixel) and split into ten classes with C4 symmetry imposed. Two new classes, comprising a total of 67,034 particles, exhibited structural features of a quality that warranted further processing. These 67,034 particle images were extracted without binning (0.98 Å per pixel), refined with C4 symmetry using the same reference (unbinned) as the prior round of classification low-pass filtered to 40 Å, and post-processed. The resulting map was used for the final round of 3D classification in which the two best classes from the prior round of 3D classification were without binning, and with C4 symmetry imposed, classified into 10. The four best classes, comprising 46,124 particle images, were refined together and post-processed to generate the final 3.6 Å map. This relatively small number of particles compared to the initial pool of picked up 509,569 particles indicates that the majority of picked up particles represent either artefacts or contaminants or TRPV6 molecules in alternative conformations including different gating states or unnatural conformations produced by the artificial environment of the cryo-EM grid.
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Each dataset was processed using a workflow similar to that described above and the reported resolutions were estimated using the Fourier shell correlation (FSC = 0.143) criterion on masking-effect-corrected FSC curves calculated between two independent half maps 39, 40 . The local resolutions were estimated with unfiltered half maps using ResMap 41 and EM density maps were visualized using UCSF Chimera 42 .
The cryo-EM data collected for full-length rTRPV6 yielded a low-resolution (6.4 Å) reconstruction that was sufficient to conclude that it represents a closed-state conformation similar to rTRPV6*. As it is lacking high-resolution detail, it is not described in the main text or Extended Data. Model building.
To build the open-and closed-state models of TRPV6 in COOT 43 , we used the rTRPV6* crystal structure 10 as a guide. The resulting models were refined against unfiltered half maps in real space with constraints using PHENIX 44 . The refined models were tested for overfitting (Extended Data  Figs 2f, 3f, 6f, 7f ) by shifting their coordinates by 0.5 Å with shake in PHENIX and building their corresponding densities in Chimera 42 from the shaken models. FSC was calculated between the densities from the shaken models, the half maps used in PHENIX refinement (work), the second half maps (free) and the unfiltered sum maps, using EMAN2 45 . The local resolutions in the transmembrane regions of our hTRPV6 in nanodiscs and hTRPV6(R470E) maps reached 2.5 Å as estimated by ResMap 41 . These high resolutions allowed us to unambiguously define the conformation of S6 in the open and closed states as well as the existence of the π-helix in the extracellular half of S6 in the open state. Structures were visualized and figures were prepared in Pymol 46 . Fura 2-AM measurements. Wild-type hTRPV6 or hTRPV6(R470E) fused to C-terminal streptavidin tag was expressed in HEK 293 cells. Cells were harvested 50-60 h after transduction by centrifugation at 600g for 5 min. The cells were resuspended in pre-warmed modified HEPES-buffered saline (HBS) (118 mM NaCl, 4.8 mM KCl, 1 mM MgCl 2 , 5 mM d-glucose, 10 mM HEPES pH 7.4) containing 5 μg/ml Fura2-AM (Life Technologies) and incubated at 37 °C for 45 min. The loaded cells were then centrifuged for 5 min at 600g, resuspended in prewarmed, modified HBS, and incubated again at 37 °C for 25-35 min in the dark. The cells were subsequently pelleted and washed twice, then resuspended in modified HBS for experiments. The cells were kept on ice in the dark for a maximum of ~2 h before fluorescence measurements, which were conducted using a spectrofluorometer QuantaMaster 40 (Photon Technology International) at room temperature in a quartz cuvette under constant stirring. Intracellular Ca 2+ was measured by taking the ratio of two excitation wavelengths (340 and 380 nm) at one emission wavelength (510 nm). The excitation wavelength was switched at 1-s intervals. Electrophysiology. HEK 293 cells (ATCC #CRL-1573) were grown on glass cover slips in 35-mm dishes and were transduced with the same P2 virus as was used for large-scale protein production. Recordings were made at room temperature, 36-72 h post-transduction. Currents from whole cells, typically held at a 0 or −60 mV membrane potential, were recorded using an Axopatch 200B amplifier (Molecular Devices, LLC), filtered at 5 kHz and digitized at 10 kHz using a low-noise data acquisition system (Digidata 1440A) and pCLAMP software (Molecular Devices, LLC). The external solution contained (in mM): 140 NaCl, 6 CsCl, 1 MgCl 2 , 10 HEPES pH 7.4 and 10 glucose. To evoke monovalent currents, 1 mM EGTA was added to the external solution. The internal solution contained (in mM): 100 CsAsp, 20 CsF, 10 EGTA, 3 MgCl 2 , 4 NaATP and 20 HEPES pH 7.2.
TRPV6 currents were recorded in response to 50-ms voltage ramps from −120 mV to 120 mV (see Extended Data Fig. 1 ). Data analysis was performed using the computer program Origin 9.1.0 (OriginLab Corp.). Data availability. Cryo-EM density maps have been deposited in the Electron Microscopy Data Bank (EMDB) under accession numbers EMDB-7120 (hTRPV6 in nanodiscs), EMDB-7121 (hTRPV6 in amphipols), EMDB-7122 (hTRPV6(R470E)) and EMDB-7123 (rTRPV6*). Model coordinates have been deposited in the Protein Data Bank (PDB) under accession numbers 6BO8 (hTRPV6 in nanodiscs), 6BO9 (hTRPV6 in amphipols), 6BOA (hTRPV6(R470E)) and 6BOB (rTRPV6*). All other data are available from the corresponding author upon request.
Extended Data Figure 1 | Functional characterization of wild-type and mutant hTRPV6 channels. a-d, Whole-cell patch-clamp recordings from HEK 293 cells expressing wild-type hTRPV6 (a), hTRPV6(R470E) (b), hTRPV6(Q483A) (c) and hTRPV6(A566T) (d). Leak-subtracted currents (blue) are shown in response to voltage ramp protocols illustrated above the recordings. Although the shapes of the currents for wild-type and mutant hTRPV6 channels were similar, their amplitudes were different. The average current amplitudes at −60-mV membrane potential (mean ± s.e.m.) were 3,171 ± 767 pA (n = 11) for wild-type hTRPV6; 918 ± 267 pA (n = 9) for hTRPV6(R470E); 2,239 ± 398 pA (n = 7) for hTRPV6(Q483A); and 145 ± 52 pA (n = 5) for hTRPV6(A566T). e-h, Kinetics of calcium uptake using Fura-2 AM ratiometric fluorescence measurements. Representative fluorescence curves are shown for wild-type hTRPV6 (e), hTRPV6(R470E) (f), hTRPV6(Q483A) (g) and hTRPV6(A566T) (h) in response to application of 2 mM Ca 2+ (arrow). Exponential fits are shown in red, with the time constants indicated. Over five measurements, the time constants (mean ± s.e.m.) were 4.2 ± 0.5 s for hTRPV6; 47 ± 13 s for hTRPV6(R470E); 18.9 ± 0.8 s for hTRPV6(Q483A); and 121 ± 12 s for hTRPV6(A566T). At n = 5 and P = 0.05, the time constant values for wild-type and mutant channels were statistically different (two-sided t-test). i, j, Fluorescence curves for wild-type hTRPV6 (i) and hTRPV6(R470E) (j) in response to application of 2 mM Ca 2+ after pre-incubation of cells in different concentrations of 2-APB. These experiments were repeated independently three times with similar results. k, Dose-response curves for 2-APB inhibition calculated for wild-type hTRPV6 (black) and hTRPV6(R470E) (red) (n = 3 for all measurements). The changes in the fluorescence intensity ratio at 340 and 380 nm (F 340 /F 380 ) evoked by addition of 2 mM Ca 2+ after pre-incubation with various concentrations of 2-APB were normalized to the maximal change in F 340 /F 380 after addition of 2 mM Ca 2+ in the absence of 2-APB. Curves through the data points are fits with the logistic equation, with the mean ± s.e.m. values of half maximal inhibitory concentration (IC 50 ), 274 ± 27 μM and 85 ± 5 μM, and the maximal inhibition, 72.6 ± 2.7% and 50.3 ± 1.1%, for hTRPV6 and hTRPV6(R470E), respectively. The leftward shift of the 2-APB dose-response curve of hTRPV6(R470E), when compared to the dose-response curve of wild-type hTRPV6, indicates an increased affinity of the channel for 2-APB. This is likely to result from the R470E mutation reducing the affinity of the channel for an activating lipid ligand. On the other hand, the reduced maximum inhibition of hTRPV6(R470E) at high concentrations of 2-APB, when compared to that of wild-type hTRPV6, indicates a reduced efficacy of 2-APB that could be a result of the R470E mutation disrupting the mechanism by which 2-APB binding is allosterically coupled to channel gating.
Extended Data Figure 7 | Overview of single-particle cryo-EM for rTRPV6 in CNW11 nanodiscs. a, Example cryo-EM micrograph for rTRPV6 in CNW11 nanodiscs with example particles circled in red. b, Reference-free 2D class averages of rTRPV6 in CNW11 nanodiscs illustrating different particle orientations. c, Local resolution mapped on density at 0.011 threshold level (UCSF Chimera) calculated using Resmap and two unfiltered half maps, with the highest resolution observed for the channel core. d, Orientations of particles that contribute to the final 3.9 Å reconstruction. Longer red rods represent orientations that comprise more particles. e, FSC curve calculated between half maps. f, Cross-validation FSC curves for the refined model versus unfiltered half maps (only half map1 was used for PHENIX refinement) and the unfiltered summed map. Corresponding author(s): Alexander Sobolevsky
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Experimental design 1. Sample size
Describe how sample size was determined. Amount of cryo-EM data collected was limited by time allocation at the microscopes. No statistical methods were used to predetermine sample sizes.
Data exclusions
Describe any data exclusions. No data have been excluded.
Replication
Describe whether the experimental findings were reliably reproduced.
No replication attempts have failed. All cryo-EM data collections were consistent from the beginning to the end.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Samples were not randomized for the experiments.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding techniques were used.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
